Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7292 p370
27 March 2004

This article
Reprint
Photocopy


News summary

Related websites
Archives of Disease in Childhood abstract (more)


Immediate action urged as MRSA in children rises

Researchers have called for urgent action to tackle rising rates of infection with methicillin-resistant Staphylococcus aureus in children.

They found a rapid rise over 10 years in the incidence of MRSA infection in children as well as in adults. Rates among children had previously been thought to be low because they spend less time in hospital, usually separate from adult services.

In 1991, 5 per cent of all blood samples positive for S aureus in adults and children were resistant to methicillin. By 2000, this proportion had reached 42 per cent.

A new analysis of reports filed to the Health Protection Agency communicable disease surveillance centre between 1990 and 2001 showed 376 reports of MRSA among children up to the age of 15 years. The numbers of MRSA-positive samples as a proportion of all S aureus infections in children rose from four (0.9 per cent) in 1990 to 77 (13.1 per cent) in 2001. Infants under one year accounted for 53 per cent of cases. It was not known where infections were acquired.

The authors warn that MRSA infections are usually resistant to multiple antibiotics, with vancomycin resistance increasing. Action must be taken now to ensure that infection rates do not rise to adult levels, the authors urge. They call for an immediate national review of risk factors and for control measures to be put in place.

An accompanying editorial by a US microbiologist says that MRSA among children in the community could make common childhood skin infections, such as impetigo, extremely difficult to treat. He adds that, in his experience, hospital-acquired MRSA in children is often related to new staff carrying MRSA acquired at other hospitals (Archives of Disease in Childhood 2004;89:378).

Paediatric pharmacist Ghi Pei Khoo, team leader women and children, St George’s Hospital, London, said that her special care baby unit was careful in its choice of antibiotics, maintaining awareness of resistance patterns. She added that barrier nursing was one of the most effective means to control infection and that these measures were always used with babies transferred to the St George’s unit from other hospitals.

Back to Top


©The Pharmaceutical Journal